Jump to content

Draft:Ian Walker (researcher)

From Wikipedia, the free encyclopedia
(Redirected from Draft:Ian Walker)
  • Comment: The title of this draft either has been disambiguated or will need to be disambiguated for acceptance.
    If the title of this draft has been disambiguated, submitters and reviewers are asked to check the disambiguated title to see if it is the most useful disambiguation, and, if necessary, rename this draft.
    If this draft is accepted, the disambiguation page will need to be edited. Either an entry will need to be added, or an entry will need to be revised. Please do not edit the disambiguation unless you are accepting this draft.
    The disambiguation page for the primary name is Ian Walker (disambiguation). Robert McClenon (talk) 20:28, 2 April 2025 (UTC)

Dr
Ian Walker
Born1978 (age 46–47)
Alma materUniversity of Leeds
Warwick Business School
Harvard Medical School
EmployerCancer Research UK
Organization(s)Association of Medical Research Charities
National Cancer Research Institute
Institut Gustave Roussy
The Pirbright Institute

Dr Ian Walker sits on the Executive Board at Cancer Research UK, the world’s largest independent medical research charity. He has over two decades of experience in advancing cancer prevention, diagnosis and treatment. He is on the Board of Trustees at The Pirbright Institute.[1]

Education and early life

[edit]

Walker grew up in Barnsley, South Yorkshire. He was the first in his family to attend university and studied Biochemistry at the University of Leeds. He earned a bachelor’s degree in 1999, followed by a PhD in 2003 for his thesis on the development and characterisation of photosensitisers for targeting in photodynamic therapy. In 2012, he was awarded a Master of Business Administration degree with distinction from Warwick Business School.

Career and research

[edit]

Walker joined Cancer Research UK in 2006 and was appointed Director of Clinical Research and Strategic Partnerships in 2013. He has held a position on the Executive Board since 2021 and is responsible for delivering the charity’s strategic objectives and maximising its impact for people affected by cancer.[2]

He has led Cancer Research UK’s campaign to make the UK smokefree, giving evidence at the Tobacco and Vapes Bill Committee and urging MPs to support the world-leading legislation to raise the age of sale for tobacco products in the UK.[3][4] He also provided oral evidence to the Petitions Committee on brain tumour and childhood cancer research.[5][6]

Walker is a Trustee at The Pirbright Institute and a Member of Institut Gustave Roussy’s International Scientific Board.[7] He previously served terms as a Trustee at the Association of Medical Research Charities and National Cancer Research Institute. He also contributes to the National NHS Genomics Board and UK Government Major Conditions Strategy Steering Board.

His research focused on the role of photodynamic therapy in cancer treatment. He has published several papers during his career including in Nature Reviews, The Lancet Oncology and the British Journal of Haematology.[8][9]

Awards and honours

[edit]

Walker has been named in PRWeek’s Power Book three times in the past four years, topping the list twice.[10]  

References

[edit]
  1. ^ "Board of Trustee Directors". The Pirbright Institute. Retrieved 1 April 2025.
  2. ^ "Chief Executive and Executive Board". Cancer Research UK. Retrieved 1 April 2025.
  3. ^ "Smokefree UK". Cancer Research UK. Retrieved 1 April 2025.
  4. ^ "Tobacco and Vapes Bill (First sitting)". Hansard. Retrieved 1 April 2025.
  5. ^ "Brain tumour and childhood cancer research inquiry". Parliamentary committees of the United Kingdom. Retrieved 1 April 2025.
  6. ^ "Petitions Committee evidence session on brain tumour & childhood cancer research". YouTube. Retrieved 1 April 2025.
  7. ^ "International Scientific Board". Institut Gustave Roussy. Retrieved 1 April 2025.
  8. ^ "Do molecularly targeted agents in oncology have reduced attrition rates?". Nature Reviews. 14 November 2008.
  9. ^ "The present and future role of photodynamic therapy in cancer treatment". The Lancet Oncology. 5 (8): 497–508. August 2004.
  10. ^ "Charity/NGO comms – PRWeek Power Book 2025 Top 10". PRWeek. Retrieved 1 April 2025.